During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or has certain genetic disorders or anomalies. This information can help ...

GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal ...

NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

As prenatal genetic testing becomes more common, experts explain what these tests can and cannot predict, how parents should ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal test ...

Genedx Holding Corp. launched Genomedx Prenatal, its whole genome sequencing test, to provide more definitive diagnoses of the causes of fetal abnormalities identified by ultrasound. By combining the ...

Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways continue to evolve globally helping ...

LONDON - JULY 18: (Photo illustration by Daniel Berehulak/Getty Images) Over time, non-invasive screening studies were developed that were easier and safer for pregnant patients. Early versions of ...